CYT-338 NK Cell Engager Mutispecific Antibody Engagement of NKp46 Activation Receptor Overcomes Anti-CD38 Mab Mediated Fratricide of NK Cells and Accords Enhanced Cancer Immunotherapy
Year: 2023
Type: conference-abstract
Source: Blood
Institutions: Hebrew University of Jerusalem, City Of Hope National Medical Center, City of Hope, University of Miami, Sylvester Comprehensive Cancer Center, National Institutes of Health, United States Food and Drug Administration, Center for Drug Evaluation and Research, Center for Cancer Research
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4389219476
